Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Shanghai Pharmaceuticals Holding Co., Ltd    601607   CNE000000C82

SHANGHAI PHARMACEUTICALS HOLDING CO., LT

(601607)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
02/11/2020 02/12/2020 02/13/2020 02/14/2020 02/17/2020 Date
19.7(c) 19.67(c) 20.81(c) 19.94(c) 20.16(c) Last
32 716 033 26 462 331 58 910 389 43 262 407 35 660 022 Volume
-1.35% -0.15% +5.80% -4.18% +1.10% Change
More quotes
Financials (CNY)
Sales 2019 186 B
EBIT 2019 6 849 M
Net income 2019 4 362 M
Debt 2019 19 266 M
Yield 2019 2,35%
Sales 2020 208 B
EBIT 2020 7 484 M
Net income 2020 4 858 M
Debt 2020 15 756 M
Yield 2020 2,72%
P/E ratio 2019 13,2x
P/E ratio 2020 12,0x
EV / Sales2019 0,38x
EV / Sales2020 0,33x
Capitalization 52 050 M
More Financials
Company
Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its... 
Sector
Drug Retailers
Calendar
03/28Earnings Release
More about the company
Surperformance© ratings of Shanghai Pharmaceuticals H
Trading Rating : Investor Rating :
More Ratings
Latest news on SHANGHAI PHARMACEUTICALS H
01/22ENZYMATICA PUBL : signs agreement with Keyuan Trade for China
AQ
2019SHANGHAI PHARMACEUTICALS : Grant of share options under the share option scheme
PU
2019SHANGHAI PHARMACEUTICALS : Results of the extraordinary general meeting, a share..
PU
2019SHANGHAI PHARMACEUTICALS : Notification Letter and Change Request Form to Regist..
PU
2019SHANGHAI PHARMACEUTICALS : Reply slip for holders of h share attending the 2019 ..
PU
2019SHANGHAI PHARMACEUTICALS : Form of proxy of holders of h shares for use at the 2..
PU
2019SHANGHAI PHARMACEUTICALS : Proxy form of the independent non-executive director ..
PU
2019SHANGHAI PHARMACEUTICALS : Notice of 2019 second h share class meeting
PU
2019SHANGHAI PHARMACEUTICALS : Reply slip for holders of h share attending the 2019 ..
PU
2019SHANGHAI PHARMACEUTICALS : Proxy form of holders of h shares for use at the 2019..
PU
2019SHANGHAI PHARMACEUTICALS : Proxy form of the independent non-executive director ..
PU
2019SHANGHAI PHARMACEUTICALS : Proposed Adoption of the 2019 Share Option Scheme Ass..
PU
2019SHANGHAI PHARMACEUTICALS : Proposed adoption of the share option scheme and the ..
PU
2019SHANGHAI PHARMACEUTICALS : Csrc's approval on issuance of new h shares
PU
2019SHANGHAI PHARMACEUTICALS : Notification Letter and Change Request Form to Regist..
PU
More news
News in other languages on SHANGHAI PHARMACEUTICALS H
2019SHANGHAI PHARMACEUTICALS HOLDING CO : Ex-dividend day for final dividend
2018SHANGHAI PHARMACEUTICALS HOLDING CO : Ex-dividend day for final dividend
2018Ardian lance la vente de l'allemand Riemser Pharma
2017SHANGHAI PHARMACEUTICALS : Vers une cession du fabricant américain de génériques..
2017SHANGHAI PHARMACEUTICALS HOLDING CO : Veröffentlichung des Halbjahresergebnisse..
More news
Analyst Recommendations on SHANGHAI PHARMACEUTICALS H
More recommendations
Stock Trading Strategies
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD - 01/03
A technical turn-around configuration
BUY
More Stock Trading Analysis
Sector news : Drug Retailers - NEC
02/17Cathay Pacific flags 'significant' drop in first-half profit, capacity cuts d..
RE
02/17Cathay Pacific flags 'significant' drop in first-half profit, capacity cuts d..
RE
02/14Highlights of the 16-year Airbus, Boeing trade war
RE
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
More sector news : Drug Retailers - NEC
Chart SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Duration : Period :
Shanghai Pharmaceuticals Holding Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI PHARMACEUTICALS H
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 20,94  CNY
Last Close Price 20,16  CNY
Spread / Highest target 30,5%
Spread / Average Target 3,85%
Spread / Lowest Target -29,0%
EPS Revisions
Managers
NameTitle
Da Wei Liu Deputy Chief Executive Officer
Min Zuo President & Executive Director
Jun Zhou Chairman
Bo Shen Chief Financial Officer, Executive Director & VP
Zu Chi Xie Independent Non-Executive Director
Sector and Competitors